DUBLIN--(BUSINESS WIRE)--The "Global Cancer Monoclonal Antibodies Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
The cancer monoclonal antibodies market is poised to grow by $33.1 bn during 2021-2025, progressing at a CAGR of 8.23%
The market is driven by the increase in demand for ADCs and awareness and initiatives taken by vendors and government.
The report on cancer monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The cancer monoclonal antibodies market analysis includes the type segment and geographic landscape.
This study identifies the strong R&D pipeline as one of the prime reasons driving the cancer monoclonal antibodies market growth during the next few years.
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer monoclonal antibodies market vendors that include Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA.
Also, the cancer monoclonal antibodies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Key Topics Covered:
Executive Summary
- Market overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Naked monoclonal antibodies - Market size and forecast 2020-2025
- Conjugated and bi-specific monoclonal antibodies - Market size and forecast 2020-2025
- Market opportunity by Type
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bristol Myers Squibb Co.
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Inc.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
Appendix
For more information about this report visit https://www.researchandmarkets.com/r/zlgit
